Vitiligo. Vitiligo
Conditions
Interventions
Intervention 1: In first group that were treated with PUVA (30 patients), oral tablets containing 8-methoxypsoralen at a dose of 25 mg/ m2 were taken 3 hours before phototherapy and PUVA therapy was
Treatment - Drugs
In first group that were treated with PUVA (30 patients), oral tablets containing 8-methoxypsoralen at a dose of 25 mg/ m2 were taken 3 hours before phototherapy and PUVA therapy was started at a dos
In second group (30 patients), UVB therapy was administered twice a week with 311-313 nm wavelength and a dose of 0.1 J/cm2 and we increased the dose 20% in each visit if tolerated.Phototherapy sessio
Sponsors
Islamic Azad University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:vitiligo patients 18 to 70 years; patients who use PUVA or UVB Exclusion criteria: previous skin cancer; failure of previous treatment with phototherapy; more than 100 sessions of phototherapy in the person's life; treatment for vitiligo in the last three months; pregnancy and lactation; liver or kidney disease; lupus erythematosus; history of sensitivity to light;use ointment monobanzen.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vitiligo. Timepoint: Three months every two weeks and And in the next three months per month. Method of measurement: Observe and record. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBIta Shahbazzadegan
Ardabil University of Medical Sciences
Outcome results
None listed